Dear Editor,

 {#jde14093-sec-0001}

Scratch dermatitis, or flagellate erythema, is characterized by linear erythematous/hyperpigmented streaks, and can be caused by shiitake mushroom, bleomycin, dermatomyositis and Still\'s disease.[1](#jde14093-bib-0001){ref-type="ref"} Engraftment syndrome (ES) presents with pyrexia, maculopapular eruption and edema during neutrophil recovery following hematopoietic stem cell transplantation.[2](#jde14093-bib-0002){ref-type="ref"} Here, we describe a case with scratch dermatitis encountered as a clinical manifestation of ES.

A 44‐year‐old Japanese woman was referred to us with a 2‐day history of distinct scratch marks due to severe pruritus 18 days after unrelated allogeneic bone marrow transplantation (BMT) from an unrelated donor to treat blast crisis of chronic myeloid leukemia. Human leukocyte antigens between patient and donor were matched at eight of eight loci serologically, and seven of eight loci by DNA typing (mismatch for *DRB1*). The patient denied having eaten shiitake mushrooms recently. Neither bleomycin nor peplomycin had been administrated. Physical examination showed severe pruritus and erythematous streaks on the trunk on post‐BMT day 18 (Fig. [1](#jde14093-fig-0001){ref-type="fig"}a). Maculopapular eruptions appeared on the trunk and extremities on day 19 (Fig. [1](#jde14093-fig-0001){ref-type="fig"}b). No diarrhea or jaundice was observed. Bodyweight was 56.0 kg, 57.2 kg and 56.2 kg on day 16, 18--21 and 22, respectively. Maximum daily axillary temperature was 37.9°C on day 16, 39.5°C on day 17, 39.1°C on day 18, 39.5°C on day 19 and 38.0°C on day 20. Neutrophil counts were 400/μL on day 16, 1300/μL on day 18 and 3500/μL on day 19. Aspartate transaminase and alanine transaminase concentrations were 173 IU/mL and 340 IU/mL, respectively, on day 18. Histopathological examination of the streaks on the maculopapular eruptions revealed minimal individual cell keratinization, mild vacuolar degeneration (Fig. [1](#jde14093-fig-0001){ref-type="fig"}c) and markedly low counts of CD1a‐positive cells in the epidermis (Fig. [1](#jde14093-fig-0001){ref-type="fig"}d). Based on these findings, ES was diagnosed. All symptoms including eruptions improved over a few days without specific treatment and without any change in the pharmacotherapy being administrated.

![(a) Cutaneous manifestations on post‐bone marrow transplantation (BMT) day 18. Pruritus and erythematous streaks are apparent on the trunk. (b) Cutaneous manifestations on post‐BMT day 19. Maculopapular eruptions are evident on the lateral region of the trunk. (c) Histopathological findings of erythematous streaks on the macular eruption (hematoxylin--eosin stain, ×200). Minimal individual keratinization, mild vacuolar degeneration and mild lymphocyte infiltration in the upper dermis are seen. Few eosinophils are present. (d) Immunohistochemical staining using anti‐CD1a antibodies (Dako, Santa Clara, CA,USA) (×200). Few CD1a‐positive cells are evident in the epidermis.](JDE-45-e25-g001){#jde14093-fig-0001}

Major diagnostic criteria of ES are body temperature of 38.0°C or more, erythrodermatous rash involving more than 25% of the body surface area and non‐cardiogenic pulmonary edema.[2](#jde14093-bib-0002){ref-type="ref"} Minor criteria are hepatic dysfunction with either total bilirubin of more than 2.0 mg/dL or transaminase levels over double the upper limit of normal, renal insufficiency, weight gain of 2.5% or more and transient encephalopathy. The presence of all three major criteria or two major criteria and one or more minor criteria is diagnostic of ES, and our case fulfilled these criteria. Scratch dermatitis might have been attributable to the severe itch that preceded maculopapular eruptions.

The present case was not compatible with urticaria based on the histopathological findings, and the possibility of drug eruption was negated by the improvement in symptoms seen without changes in the pharmacotherapy being administrated. Although a previous report suggested CD4^+^ cell predominance and decreased numbers of CD1a^+^ cells in the epidermis as suggestive of ES rather than graft‐versus‐host disease (GVHD),[3](#jde14093-bib-0003){ref-type="ref"} these findings are not definitive points of differentiation between ES and GVHD. This report suggests scratch dermatitis as a potential early sign of ES and means of distinguishing ES from GVHD as early as possible.
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